260 filings
Page 3 of 13
EFFECT
fgk24 jfdpi9
10 Apr 23
Notice of effectiveness
12:15am
424B3
u6m9pinafkv es
7 Apr 23
Prospectus supplement
5:11pm
CORRESP
kz6ez11htoe
7 Apr 23
Correspondence with SEC
12:00am
CORRESP
ioov2
7 Apr 23
Correspondence with SEC
12:00am
8-K
5y359jqax
5 Apr 23
NUTEX HEALTH announces change to its board of directors
5:19pm
UPLOAD
yrhs 3tm59rj6iyh
5 Apr 23
Letter from SEC
12:00am
S-3
h2qmld5pnc
27 Mar 23
Shelf registration
6:40pm
POS AM
j6n5vpdpo
10 Mar 23
Prospectus update (post-effective amendment)
5:25pm
8-K
2m6i zil40uy8yky
2 Mar 23
NUTEX HEALTH Inc. reports fourth quarter and Full YEAR 2022 financial results
5:29pm
NT 10-K
31lecr5l05nrw
2 Mar 23
Notice of late annual filing
5:17pm
8-K
3amzjgyag0us9ovwukqt
27 Feb 23
Regulation FD Disclosure
5:44pm
S-3ASR
79bdfjmj
11 Jan 23
Automatic shelf registration
7:10pm
8-K
i5kmlgwh dee5z4r52
4 Jan 23
Departure of Directors or Certain Officers
4:02pm
8-K
1a9 vbgisrv1jsy
21 Dec 22
NUTEX HEALTH to present at the 41st Annual J.P. Morgan Healthcare conference
4:45pm
8-K
nuvy94cjfc 6whcpf
21 Nov 22
NUTEX HEALTH reports THIRD quarter 2022 financial results and announces Common stock purchase agreement for a commitment to purchase up to $100 million worth of shares of its common stock with
6:40pm
8-K
uexu0rkrgk9r6jlp8
18 Nov 22
Entry into a Material Definitive Agreement
4:59pm
NT 10-Q
r28j lz5duejb
15 Nov 22
Notice of late quarterly filing
4:02pm